TCM
TCG Crossover Management Portfolio holdings
AUM
$876M
This Quarter Return
+22.45%
1 Year Return
+23.66%
3 Year Return
+996.72%
5 Year Return
–
10 Year Return
–
AUM
$679M
AUM Growth
+$679M
(+11%)
Cap. Flow
+$110M
Cap. Flow
% of AUM
16.18%
Top 10 Holdings %
Top 10 Hldgs %
61.79%
Holding
30
New
8
Increased
3
Reduced
2
Closed
4
Top Buys
| 1 |
Structure Therapeutics
GPCR
|
$58.1M |
| 2 |
Savara
SVRA
|
$37.8M |
| 3 |
Taysha Gene Therapies
TSHA
|
$35.1M |
| 4 |
INBX
Inhibrx, Inc. Common Stock
INBX
|
$32.1M |
| 5 |
CMPS
Compass Pathways
CMPS
|
$28.5M |
Top Sells
| 1 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$96.3M |
| 2 |
VECT
VectivBio Holding AG Ordinary Shares
VECT
|
$52.9M |
| 3 |
Immunovant
IMVT
|
$12.3M |
| 4 |
Aclaris Therapeutics
ACRS
|
$5.49M |
| 5 |
ALPN
Alpine Immune Sciences, Inc. Common Stock
ALPN
|
$2.6M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
C4 Therapeutics
CCCC
$185M
| $2.37M | 0.35% |
1,276,574
| – | – |
|
|
27
Aclaris Therapeutics
ACRS
$209M
| – | – |
-529,839
| Closed | -$5.49M |
|
|
ALPN
28
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| – | – |
-253,069
| Closed | -$2.6M |
|
|
ISEE
29
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-2,448,829
| Closed | -$96.3M |
|
|
VECT
30
DELISTED
VectivBio Holding AG Ordinary Shares
VECT
| – | – |
-3,113,600
| Closed | -$52.9M |
|